课题基金 / 基金详情

Clinical Significance of Platelet Allo-antibodies.

Clinical Significance of Platelet Allo-antibodies.
血小板同种抗体的临床意义。
批准号:
06454617
负责人:
SHIBATA Yoichi
金额:
$4.42万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for General Scientific Research (B)
财政年份:
1994
资助国家:
日本
项目状态:
已结题
起止时间:
1994 至 1995

项目摘要

项目成果

SHIBATA Yoichi的其他基金

相关文献

中文摘要
翻译
1)我们无法用我们的血小板检测日本人的Mo^a, Sr^a或Va^a抗原。相比之下,约5%(15/314)被发现为Tu^a阳性。2)新生儿同种免疫性血小板减少症29例:抗hpa -4b (YuK^a)抗体20例,抗hpa -4a (YuK^ b)抗体3例,抗hpa -3a (Bak^a)抗体5例,抗hpa -5b (Br^a)抗体1例。其中合并颅内出血3例。3)通过大量样本的筛选,我们发现抗hpa -2b (Sib^a)在血小板输注难耐病例中起重要作用。4)混合被动血凝法(MPHA)是15年前发展起来的一种检测抗血小板抗体的简便、灵敏的方法。现在它已经被改进了。使用5%的蔗糖,血小板固定板可以冷冻(低于40℃)保存一年以上而不丧失反应性。因此,MPHA应作为医院任何实验室检测血小板同种抗体的常规检查。
英文摘要
1) We were unable to detect Mo^a, Sr^a or Va^a antigens among Japanese using our platelet-panel. In contrast, about 5% (15/314) were found to be Tu^a positive.2) We have experienced 29 cases of NAIT (Neonatal Alloimmune Thrombocytopenia) : 20 cases due to anti-HPA-4b (YuK^a) antibodies, 3 cases due to anti-HPA-4a (Yuk^b), 5 cases due to anti-HPA-3a (Bak^a) and 1 case due to anti-HPA-5b (Br^a). Among them 3 cases were complicated with intracranial hemorrhage.3) By screening a large number of samples, we found that anti-HPA-2b (Sib^a) playd an important role in the case of platelet transfusion refractoriness.4) The MPHA (mixed passive hemagglutination) method was developed about 15 years ago as a simple and sensitive test for the detection of anti-platelet antibodies. It has been refined now. Using 5% sucrose, the platelet-fixed plate can be kept frozen (below-40 C) without loss of reactivities for more than a year. Thus, MPHA should be employed as the routine test in any lab in the hospital for the detection of platelet allo-antibodies.
期刊论文(34)
专著(0)
科研奖励(0)
会议论文
Fujiwara K.et al.: "DNA-Based Typing of Human Platelet Antigen Systems by PCR-SSCP(Single-Strand Conformation Polymorphism)Method." Vox Sang. 69. 347-351 (1995)
Fujiwara K.等人:“通过 PCR-SSCP(单链构象多态性)方法对人类血小板抗原系统进行 DNA 分型。”
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Araki N et al: "Anti-HLA Antibody Screeing with Platelet Soluble HLA Antigens by MPHA Method." VOX Sang. 69. 222-230 (1995)
Araki N 等人:“通过 MPHA 方法用血小板可溶性 HLA 抗原筛选抗 HLA 抗体。”
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Tanaka S., Taniue A., Nagao N., Ohnoki S., Tomita T., Shibata H., Okubo Y., Yamaguchi H., Shibata Y.: "Genotype frequencies of the human platelet antigen, Ca/Tu, in Japanese, determined by a PCR-RFLP method" Vox Sang. 70. 40-44 (1996)
Tanaka S.、Taniue A.、Nagao N.、Ohnoki S.、Tomita T.、Shibata H.、Okubo Y.、Yamaguchi H.、Shibata Y.:“人类血小板抗原 Ca/Tu 的基因型频率,
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Lin M et al: "Neonatal Alloimmune Thrombocytopenia in Taiwan Due to an Antibody against a Labile Component of HPA-3a(Bak^a)" VOX Sanginis. 69. 336-340 (1995)
Lin M 等人:“台湾新生儿同种免疫血小板减少症因针对 HPA-3a(Bak^a) 不稳定成分的抗体而引起”VOX Sanginis。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
共 17 条
    Growth analysis of root crops using root diameter measurement device
    • 批准号:
      25450380
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $3.33万
    • 财政年份:
      2013
    • 负责人:
      SHIBATA Yoichi
    • 依托单位:
    Screening of anti-platelet antibodies and prospective study of neonatal alloimmune thrombocytopenia
    • 批准号:
      10470515
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $8.0万
    • 财政年份:
      1998
    • 负责人:
      SHIBATA Yoichi
    • 依托单位:
    Development of MPHA kit for detecting antiplatelet antibodies.
    • 批准号:
      08557149
    • 项目类别:
      Grant-in-Aid for Scientific Research (A)
    • 资助金额:
      $13.18万
    • 财政年份:
      1996
    • 负责人:
      SHIBATA Yoichi
    • 依托单位: